# Nurix Therapeutics, Inc.: Form DEF 14A, filed Mar 27, 2024

- Company: [Nurix Therapeutics, Inc.](/companies/nrix.md) (CIK 1549595)
- Form: DEF 14A
- Filed: 2024-03-27
- Accepted by EDGAR: Mar 27, 2024, 07:01 ET
- Period: 2024-05-20
- Accession: 0001140361-24-015447
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1549595/000114036124015447/ny20018253x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1549595/000114036124015447/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1549595/000114036124015447/ny20018253x1_def14a.htm

Filed Mar 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-015447. Last ingested by Listed: Nov 5, 2026, 13:59 ET. No prices; not investment advice.